EUVIMEDEUVIMED entdecken
Editorial

What FDA Clearance Does, and Does Not, Mean for Artificial Intelligence

Kyra L Rosen iD, Kenneth D Mandl iD

Annals of Internal Medicine · 2026-06 · 179 (6) · 895-897

DOI: 10.7326/annals-26-00362 ↗

Kurz gefasst

Editorial in der Zeitschrift Annals of Internal Medicine, 2026-06. Verfasst von Kyra L Rosen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Computational Health Informatics Program, Boston Children's Hospital, Boston; and Harvard Medical School, Boston, Massachusetts (K.L.R.). Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Computational Health Informatics Program, Boston Children's Hospital, Boston; and Harvard Medical School, Boston, Massachusetts (K.L.R.).
  • Computational Health Informatics Program, Boston Children's Hospital, Boston; and Departments of Pediatrics and Biomedical Informatics, Harvard Medical School, Boston, Massachusetts (K.D.M.).

ORCID-Profile: Kyra L Rosen, Kenneth D Mandl

Zitieren

APA

Rosen, K. L., & Mandl, K. D. (2026). What FDA Clearance Does, and Does Not, Mean for Artificial Intelligence. Annals of Internal Medicine, 179(6), 895-897. https://doi.org/10.7326/annals-26-00362

Vancouver

Rosen KL, Mandl KD. What FDA Clearance Does, and Does Not, Mean for Artificial Intelligence. Annals of Internal Medicine. 2026;179(6):895-897. doi:10.7326/annals-26-00362

BibTeX
@article{Rosen2026,
  author = {Rosen, Kyra L and Mandl, Kenneth D},
  title = {What FDA Clearance Does, and Does Not, Mean for Artificial Intelligence},
  journal = {Annals of Internal Medicine},
  year = {2026},
  volume = {179},
  number = {6},
  pages = {895--897},
  doi = {10.7326/annals-26-00362}
}
Kostenlos starten →